Multisite rollout to help Hispanic kids join cancer trials
Official title: Multisite Implementation of COMPRENDO (ChildhOod Malignancy Peer REsearch NavigatiOn) to improve participation of Hispanic children in cancer clinical trials
Funded at University of California, San Diego · NIH-11374939 · Data updated 2026-11-12
A nationwide study to boost enrollment of Hispanic children with cancer into clinical trials by using trained parent navigators who speak the language and understand health literacy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | July 26, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $746,052 |
| NIH project number | 5R01CA279945-04 |
| Project ID | NIH-11374939 on NIH RePORTER |
Who could benefit from this research
✓Could help
Hispanic children (and their guardians) with cancer who are eligible for clinical trials at participating sites.
✕Less likely to help
Families without access to participating sites or who choose not to enroll in trials may not benefit directly.
What this research studies
This project will build on a proven navigator approach to guide families through the cancer trial process, with culturally and linguistically tailored support. It will test how well trained parent navigators can help families understand trials, meet eligibility, and navigate consent and logistics at multiple sites. The study will focus on reducing barriers to participation and improving timely accrual of Hispanic children into cancer research. Researchers will collect data on participation rates, understanding, and decision-making to identify effective strategies for equitable trial access. Findings could inform standard practices to close disparities in pediatric cancer care.
Why it matters
Potential benefit: If successful, more Hispanic children with cancer could access life-saving trials, potentially improving survival and equity in care.
How similar studies have gone: Preliminary work suggests navigators can improve trial participation, but this multisite test aims to confirm effectiveness across diverse settings.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Aristizabal, Paula — University of California, San Diego
- Study coordinator: Aristizabal, Paula
Related research
Other NIH-funded projects on the same topics.
-
Detecting cancer risk and treatment response in NF1 nerve tumors using cfDNA markers
A doctor-led study will test blood-based DNA markers to detect when NF1-related nerve tumors become malignant and to monitor how well treatment is working.
-
Epigenetic Basis for Controlling Aggressive IDH-Mutant Gliomas
Aims to understand and shape the epigenetic changes in IDH-mutant brain tumors to restrain their growth, which could lead to new, targeted treatment options for patients.
-
US–East Africa center to prevent and detect virus-linked cancers in people with HIV
This program builds a US–East Africa research network to train local investigators and improve prevention, earlier detection, and faster connection to care for virus-related cancers in people with HIV.
-
U.S.–East Africa program to prevent, detect early, and link people with HIV-related cancers to care
This program brings U.S. and East African teams together to help people with HIV by improving prevention, earlier detection, and faster connection to care for cancers linked to the virus.
-
U.S.–East Africa center to prevent and find HIV-related cancers and speed connection to care
This program builds a U.S.–East Africa team to improve prevention, earlier detection, and faster linkage to care for people with HIV at risk for cervical cancer and Kaposi’s sarcoma.
-
Boosting TET Activity to Help Treat AML with Vitamin C
Vitamin C may help people with a type of blood cancer (AML) by boosting a natural anti-cancer pathway, potentially improving outcomes for adults with this disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.